New Projects
AHK Energy Services Ltd. is an inspection, analysis and consultancy service provider for the solid fuel sector. They are working with the University of Strathclyde to embed multidisciplinary capability in biochemistry, and environmental, energy and chemical engineering, to develop robust analytical methodology to support the creation of an index of risk of self-heating ability of biomass pellets for use within the biomass supply chain.
Anderson Bell Christie is an architecture practice, based in Glasgow, that provide services to the social housing, healthcare, education and community sectors. They are working with the Department of Architecture at the University of Strathclyde to develop and implement a data driven design process for Zero Carbon Neighbourhoods, creating a place-based community-oriented solution to deliver holistic zero carbon living within the social housing sector.
AstraZeneca is a global, science-led biopharmaceutical business whose medicines are used by millions of patients worldwide. Their purpose is to push the boundaries of science to deliver life-changing medicines. The best way they can help patients is to be science-led and share this passion with the scientific, healthcare and business communities of the UK. Their KTP is to acquire the capability of using Pair Distribution Function (PDF) analysis using either synchrotron X-rays or lab source technology to gain quantitative insight into the structure of amorphous materials, where the structural coherence extends over only a few nanometres, rendering conventional solid form monitoring techniques ineffective.
R&B Distillers Ltd., formed in 2014, are artisanal distillers of whisky and gin. In 2017, they transformed Borodale House on the Inner Hebridean Isle of Raasay into a state-of-the-art distillery and hotel. They are working with the Department of Chemical and Process Engineering at the University of Strathclyde to embed capability in electrochemical engineering processes for energy storage and conversion, biomass energy, and clean fuel technologies, to develop a holistic energy plan for decarbonisation that can be retrofitted to their current distillery site, and implemented at future planned sites.
Target Healthcare Limited (THL) manufacture and supply a wide range of
pharmaceutical products, including generic, branded and unlicensed medicines. They are working with the Strathclyde Institute of Pharmacy and Biomedical Sciences to embed an understanding of formulation, characterisation, and analysis techniques, to develop platform capability, and enable creation of a robust framework for the assessment of shelf-life and stability of a range of aseptically prepared Monoclonal Antibodies (MABs) for patient use.